AbbVie (ABBV) shares recently dropped by 7.40%, with investor sentiment impacted by reports of insider selling. This decline occurred despite many Wall Street analysts maintaining a bullish outlook on the pharmaceutical company.

AbbVie Shares Slide 7.4% on Insider Selling Concerns
ABBVInsider SellingPharmaceuticalsBiotech



